Anazao Health Recalls Morphine Sulfate Due to Fungal Contamination
Anazao Health is recalling Morphine Sulfate products because environmental sampling detected Talaromyces rotundus, a type of fungus.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, but the source text does not report any illnesses or injuries, and the contamination is a low-level fungal presence (1 CFU) detected via environmental sampling, fitting the criteria for a moderate, precautionary recall.
Plain-English summary
Coast Quality Pharmacy, LLC dba Anazao Health is recalling Morphine Sulfate in all strengths, doses, and packaging. The recall is due to a lack of processing controls, which resulted in environmental sampling revealing 1 CFU (Colony Forming Unit) of Talaromyces rotundus, a fungus.
The affected products were filled on August 26, 2019, and dispensed between August 26 and August 29, 2019, provided they remain within their expiration dates. The recall covers products distributed nationwide in the U.S.
Consumers should stop using the recalled Morphine Sulfate products and contact their healthcare provider or pharmacist for further instructions.
The recalled product
- Product
- Morphine Sulfate in all strengths, all doses and all packaging, AnazaoHealth 5710 Hoover Blvd Tampa, FL 33634.
- Manufacturer
- Coast Quality Pharmacy, LLC dba Anazao Health
- Category
- Drug — Pharmaceutical
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All lots filled 08/26/2019 and dispensed 08/26-29/2019 remaining within expiry.
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 31 recalled by Coast Quality Pharmacy, LLC dba Anazao Health under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 31 products in this recall →Related recalls
Same manufacturer · Coast Quality Pharmacy, LLC dba Anazao Health
See all →- HighProgesterone 200 mg compounded tablets recalled for embedded metal fragments
FDA (Drugs) · 2024-07-03
- ModerateAnazao Health Recalls Clonidine and Hydromorphone Due to Fungal Contamination
FDA (Drugs) · 2019-12-18
- SevereAnazao Health Recalls Hydromorphone, Baclofen, and Clonidine Combination Drugs
FDA (Drugs) · 2019-12-18
- SevereAnazao Health Recalls Compounded Sufentanil Syringes Due to Fungal Contamination
FDA (Drugs) · 2019-12-18
- SevereAnazao Health Recalls Baclofen, Clonidine, and Morphine Sulfate Due to Fungal Contamination
FDA (Drugs) · 2019-12-18
Same hazard · fungal contamination
See all →- CriticalMedline Convenience Kits Recalled for Fungal Contamination Risk
FDA (Devices) · 2026-09-23
- CriticalMedline Convenience Kits Recalled for Potential Fungal Contamination
FDA (Devices) · 2026-09-23
- SevereMedline Convenience Kits Recalled for Fungal Contamination Risk
FDA (Devices) · 2026-09-23
- CriticalMedline Convenience Kits Recalled for Potential Fungal Contamination
FDA (Devices) · 2026-09-23
- CriticalMedline Recalls Blood and Urine Collection Kits Due to Fungal Contamination
FDA (Devices) · 2026-09-23
Similar recalls
- SeverePharmedium Recalls Morphine Sulfate Injection Due to Sterility Concerns
FDA (Drugs) · 2018-02-28
- SeverePharmedium Recalls Morphine Sulfate in 5% Dextrose Due to Sterility Concerns
FDA (Drugs) · 2018-02-28
- SeverePharmakon Recalls Morphine Sulfate Bags Due to Sterility Concerns
FDA (Drugs) · 2016-07-20
- SeverePharmedium Recalls Morphine Sulfate Syringes Due to Stability Data Concerns
FDA (Drugs) · 2016-10-19
- SeverePharmedium Recalls Dexamethasone Sodium Phosphate Due to Sterility Assurance Issues
FDA (Drugs) · 2018-02-28
- SeverePharmedium Recalls Dexamethasone Sodium Phosphate Infusions Due to Sterility Concerns
FDA (Drugs) · 2018-02-28